Low Circulating Valine Associate With High Risk of Hip Fractures.

Louise Grahnemo, Anna L Eriksson, Maria Nethander, Robert Johansson, Mattias Lorentzon, Dan Mellström, Ulrika Pettersson-Kymmer, Claes Ohlsson

Journal: The Journal of clinical endocrinology and metabolism 2023;108(11):e1384-e1393

PMID: 37178220

Abstract

CONTEXT

Hip fractures constitute a major health concern. An adequate supply of amino acids is crucial to ensure optimal acquisition and remodeling of bone. Circulating amino acid levels have been proposed as markers of bone mineral density, but data on their ability to predict incident fractures are scarce.

OBJECTIVES

To investigate the associations between circulating amino acids and incident fractures.

METHODS

We used UK Biobank (n = 111 257; 901 hip fracture cases) as a discovery cohort and the Umeå Fracture and Osteoporosis (UFO) hip fracture study (hip fracture cases n = 2225; controls n = 2225) for replication. Associations with bone microstructure parameters were tested in a subsample of Osteoporotic Fractures in Men Sweden (n = 449).

RESULTS

Circulating valine was robustly associated with hip fractures in the UK Biobank (HR per SD increase 0.79, 95% CI 0.73-0.84), and this finding was replicated in the UFO study (combined meta-analysis including 3126 incident hip fracture cases, odds ratio per SD increase 0.84, 95% CI 0.80-0.88). Detailed bone microstructure analyses showed that high circulating valine was associated with high cortical bone area and trabecular thickness.

CONCLUSION

Low circulating valine is a robust predictor of incident hip fractures. We propose that circulating valine may add information for hip fracture prediction. Future studies are warranted to determine whether low valine is causally associated with hip fractures.

© The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society.

Address: Department of Internal Medicine and Clinical Nutrition, Sahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Institute of Medicine, University of Gothenburg, SE-413 45 Gothenburg, Sweden.; Region Västra Götaland, Department of Drug Treatment, Sahlgrenska University Hospital, SE-413 45 Gothenburg, Sweden.; Sahlgrenska Academy, Bioinformatics and Data Centre, University of Gothenburg, SE-413 45 Gothenburg, Sweden.; The Biobank Research Unit, Umeå University, SE-90187 Umeå, Sweden.; Geriatric Medicine, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg and Geriatric Medicine, Sahlgrenska University Hospital, 43180 Mölndal, Sweden.; Mary McKillop Institute for Health Research, Australian Catholic University, 3000 VIC, Melbourne, Australia.; Clinical Pharmacology, Department of Integrative Medical Biology, Umeå University, SE-90197 Umeå, Sweden.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.